Labless模式

Search documents
胜科纳米(688757):Labless模式持续深化,技术迭代驱动成长
China Post Securities· 2025-09-03 01:53
证券研究报告:社会服务 | 公司点评报告 股票投资评级 增持 |调整 个股表现 2025-03 2025-04 2025-05 2025-06 2025-07 2025-09 -26% -20% -14% -8% -2% 4% 10% 16% 22% 28% 胜科纳米 社会服务 资料来源:聚源,中邮证券研究所 公司基本情况 | 最新收盘价(元) | 32.07 | | --- | --- | | 总股本/流通股本(亿股)4.03 | / 0.33 | | 总市值/流通市值(亿元)129 | / 10 | | 52 周内最高/最低价 | 35.80 / 20.44 | | 资产负债率(%) | 59.4% | | 市盈率 | 145.77 | | 第一大股东 | 李晓旻 | 研究所 分析师:吴文吉 SAC 登记编号:S1340523050004 Email:wuwenji@cnpsec.com 分析师:翟一梦 SAC 登记编号:S1340525040003 Email:zhaiyimeng@cnpsec.com 胜科纳米(688757) Labless 模式持续深化,技术迭代驱动成长 l 事件 发布时间:202 ...
胜科纳米: 2025年半年度报告
Zheng Quan Zhi Xing· 2025-08-27 16:12
胜科纳米(苏州)股份有限公司2025 年半年度报告 公司代码:688757 公司简称:胜科纳米 胜科纳米(苏州)股份有限公司 胜科纳米(苏州)股份有限公司2025 年半年度报告 重要提示 一、本公司董事会及董事、高级管理人员保证半年度报告内容的真实性、准确性、完整性,不存 在虚假记载、误导性陈述或重大遗漏,并承担个别和连带的法律责任。 二、重大风险提示 公司已在本报告中描述可能存在的风险,敬请查阅"第三节管理层讨论与分析"之"四、风 险因素"部分。 三、公司全体董事出席董事会会议。 四、本半年度报告未经审计。 五、公司负责人李晓旻、主管会计工作负责人洪凯及会计机构负责人(会计主管人员)洪凯声明: 保证半年度报告中财务报告的真实、准确、完整。 六、董事会决议通过的本报告期利润分配预案或公积金转增股本预案 (未经审计)。截至 2025 年 6 月 30 日,母公司报表未分配利润为人民币 139,904,456.16 元(未 经审计)。根据《上市公司监管指引第 3 号——上市公司现金分红(2025 年修订)》及《公司章 程》的相关规定,经综合考虑投资者的合理回报和公司的长远发展,在保证公司正常经营业务发 展的前提下 ...
胜科纳米:坚守独立赛道 创造增量市场
Zheng Quan Shi Bao· 2025-05-12 17:43
Core Viewpoint - The article highlights the growth and innovative business model of Shengke Nano, a leading third-party semiconductor testing laboratory in Suzhou, which has adopted a "Labless" approach to meet the increasing demand for specialized testing services in the semiconductor industry [1][3]. Company Overview - Shengke Nano was established in 2004 in Singapore and became Southeast Asia's largest third-party chip testing laboratory by 2011. The company was founded in Suzhou in 2012 by Li Xiaomin, who identified a growing need for specialized testing as the domestic semiconductor industry advanced [4]. - The company has developed a unique "Labless" business model, similar to the "Fabless" model in semiconductor manufacturing, allowing semiconductor firms to outsource testing and analysis to specialized third-party laboratories [1][3]. Financial Performance - Shengke Nano's revenue has shown significant growth, with figures of approximately 168 million yuan in 2021, 287 million yuan in 2022, and 394 million yuan in 2023. Corresponding net profits were 27.5 million yuan, 65.6 million yuan, and 98.5 million yuan, respectively [2]. - The company currently possesses analysis instruments valued at around 800 million yuan and is actively expanding its production capacity through strategic partnerships with top global analysis instrument suppliers [2]. Market Trends - The "Labless" model is gaining traction in the semiconductor industry, driven by the increasing complexity of semiconductor technology and the rising costs associated with in-house laboratory setups [1][3]. - Shengke Nano aims to replicate the success of TSMC, which took nearly 40 years to become a leader in the chip foundry industry, by leveraging its "Labless" model to enhance the efficiency and performance of semiconductor research and development [3]. Future Outlook - Shengke Nano projects that its revenue for the first quarter of 2025 will reach between 110 million to 120 million yuan, representing a year-on-year growth of 26.78% to 38.31% [2]. - The company is positioned to play a crucial role in the ongoing advancement of the semiconductor industry, particularly as the demand for specialized testing services continues to rise [4].
淳厚基金调研上市公司胜科纳米,旗下淳厚利加混合A(011563)备受市场关注
Xin Lang Cai Jing· 2025-04-29 05:46
Group 1: Fund Overview - Chunhou Lijia Mixed A Fund, established on July 29, 2022, has a total management scale of 0.02 billion yuan [1] - The fund aims to create stable returns exceeding the performance benchmark through asset allocation while strictly controlling risks and maintaining liquidity [1] - As of April 25, 2025, the fund achieved a one-year return of 10.25%, outperforming the benchmark growth rate of 4.93% and the CSI Mixed Fund Index return of 6.33% [1] Group 2: Shareholder Structure - The proportion of institutional investors in the fund reached 9.64%, increasing by 9.64 percentage points over six months [1] - Fund employees hold 85.21% of the shares, totaling 855,500 shares [1] Group 3: Industry Insights - The semiconductor industry is experiencing rapid growth, driving a surge in demand for semiconductor testing and analysis [2] - The third-party laboratory testing and analysis market in the semiconductor sector has significant growth potential, with the Labless model gaining industry recognition [2] - Continuous R&D investments, driven by advancements in semiconductor technology, are expected to sustain the growth of third-party testing and analysis demand, particularly in advanced processes [2] Group 4: Company Service and Sales Model - The company employs a production model based on sales, implementing order-based production tailored to customer needs [2] - It focuses on quality and efficiency in testing services, continuously optimizing production processes to enhance service quality [2] - The sales model is direct, allowing the company to provide personalized testing solutions and respond promptly to customer needs [2] Group 5: Competitive Advantages - The company has a technological R&D advantage, with capabilities covering advanced processes up to 3nm, positioning it among industry leaders [2] - It holds a strong market position in the third-party testing and analysis market, with significant revenue scale and market share [2] - The company is recognized as a national-level "little giant" and has established a strong brand effect within the industry [2] - The technical team comprises individuals with experience from top institutions and global semiconductor firms, enhancing the company's technical strength [2] - The company has a unique international advantage with laboratories in both China and Singapore, differentiating it from domestic competitors [2] Group 6: Future Development Plans - The company plans to leverage its technical talent and maintain high R&D investment to capitalize on domestic semiconductor development opportunities [2] - It aims to enhance its analytical capabilities in advanced processes, packaging, high-performance chips, and third-generation semiconductor materials [2] - The company will expand its focus on failure analysis and reliability analysis for automotive-grade chips while exploring new fields like aerospace and biomedicine [2] - It intends to broaden its customer reach through a multi-point domestic layout and standardize laboratory replication to accelerate business expansion [2]
打造芯片全科医院,胜科纳米迎来科创板IPO
Jie Mian Xin Wen· 2025-03-24 06:47
Core Viewpoint - Shengke Nano is a leading enterprise in the domestic semiconductor third-party testing and analysis field, with a strong growth trajectory and significant market potential in the semiconductor industry [3][8]. Company Overview - Shengke Nano's revenue is projected to grow from 120 million yuan in 2020 to 415 million yuan in 2024, with a compound annual growth rate (CAGR) of 36.2%. The net profit after deducting non-recurring items is expected to increase from 18.89 million yuan in 2020 to 72.66 million yuan in 2024 [3]. - The company has received investments from notable institutions such as Yida Capital, Fengnian Capital, Haitong Kaiyuan, Guoke Jiahe, and Yongxin Fangzhou [3]. Industry Trends - The semiconductor industry is shifting from the traditional IDM model to a Fabless+Foundry+OSAT model, leading to increased specialization and the emergence of independent third-party testing services [4]. - The global market for semiconductor third-party laboratory testing and analysis has surpassed 3 billion USD and is expected to reach 7.5 billion USD by 2028, with demand for testing services growing faster than the overall semiconductor market [6]. Market Position - Shengke Nano holds a market share of approximately 7.86% in the domestic market for failure analysis and materials analysis, with estimated revenues of 326 million yuan in 2023 [8]. - The company focuses on high-value segments such as failure analysis, which contributes significantly to its profitability, achieving a gross margin of 54.28% in 2023, higher than its competitors [9]. R&D and Innovation - Shengke Nano invests heavily in R&D, with a research expense ratio of 10.8% in 2023, significantly higher than its peers [10]. - The company has developed over 20 core technologies and holds numerous certifications, including CNAS and CMA, and has participated in national-level research projects [11]. Client Base - The company serves a range of prominent clients, including major chip design firms like Zhaoshengwei, Qualcomm, and Broadcom, as well as leading foundries and semiconductor equipment suppliers [12]. - Shengke Nano aims to enhance its testing and analysis capabilities through its IPO, focusing on expanding its service capacity in failure analysis, materials analysis, and reliability analysis [12].